Literature DB >> 3755286

Which anti-thyroid drug?

D S Cooper.   

Abstract

Anti-thyroid drugs are widely used to treat diffuse toxic goiter (Graves' disease). Of the two drugs currently available in the United States, propylthiouracil is prescribed far more often than is methimazole (Tapazole). However, compared with propylthiouracil, methimazole can be given as a single daily dose, is cheaper, and, at low doses, is associated with less major toxicity; for these reasons, methimazole should be used for the routine management of Graves' disease when anti-thyroid drugs are selected as primary therapy. On the other hand, because of certain pharmacologic factors, propylthiouracil should be used in selected situations, particularly in patients with "thyroid storm" and in pregnant or lactating women.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3755286     DOI: 10.1016/0002-9343(86)90679-0

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  5 in total

Review 1.  Diagnosis and management of Graves' disease.

Authors:  Jody Ginsberg
Journal:  CMAJ       Date:  2003-03-04       Impact factor: 8.262

Review 2.  Clinical features and management of overdosage with thyroid drugs.

Authors:  T H Lin; R T Kirkland; J L Kirkland
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 Jul-Aug

Review 3.  Adverse effects of thyroid hormone preparations and antithyroid drugs.

Authors:  L Bartalena; F Bogazzi; E Martino
Journal:  Drug Saf       Date:  1996-07       Impact factor: 5.606

Review 4.  Drug therapy for hyperthyroidism in pregnancy: safety issues for mother and fetus.

Authors:  P Atkins; S B Cohen; B J Phillips
Journal:  Drug Saf       Date:  2000-09       Impact factor: 5.606

5.  Thyrotoxic crisis in Graves' disease: indication for immediate surgery.

Authors:  L Schaaf; M Greschner; R Paschke; K Kusterer; J Teuber; K Huck; R Schmidt; H D Säger; K H Usadel
Journal:  Klin Wochenschr       Date:  1990-11-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.